Product Image
Invitrogen™

pcDNA™3.2-DEST Mammalian Expression Vector

Die pcDNA™ Vektoren wurden für hohe, konstitutive Expression in verschiedenen Säugetierzelllinien konzipiert. Der pcDNA3.2/V5-DEST-Vektor bietet die folgenden Hauptmerkmale:•Cytomegalievirus (CMV) PromotorWeitere Informationen
Have Questions?
KatalognummerMenge
12489019
auch als 12489-019 bezeichnet
6μ g
Katalognummer 12489019
auch als 12489-019 bezeichnet
Preis (EUR)
1.080,76
Exklusiv online
1.318,00
Ersparnis 237,24 (18%)
Each
Menge:
6μ g
Preis (EUR)
1.080,76
Exklusiv online
1.318,00
Ersparnis 237,24 (18%)
Each
Die pcDNA™ Vektoren wurden für hohe, konstitutive Expression in verschiedenen Säugetierzelllinien konzipiert. Der pcDNA3.2/V5-DEST-Vektor bietet die folgenden Hauptmerkmale:

•Cytomegalievirus (CMV) Promotor für hohe Expression
attR-Standorte für Gateway™-Klonierung, ermöglicht Rekombination mit attL-flankierten Fragmenten
•C-terminal V5-Tag für einfachen Nachweis
•Neomycin-Resistenzgen für stabile Selektion
•Ampicillin-Resistenzgen und pUC-Ursprung für Selektion und Wartung in E. coli

Gateway™-Klonierung
Für alle Ihre Expressionsbedürfnisse, Invitrogen bietet modernste Gateway™-Zielvektoren für die Expression in E. coli-, Insekten-, Hefe- oder Säugetierzellen sowie für die Produktion von nativem Protein oder N- oder C-terminalen Fusionsproteinen. Alle Gateway-™Zielvektoren verfügen über att R-Stellen für die Rekombination mit jedem von attL-flankierten Fragment, unabhängig davon, ob es sich um einen Entry-Klon oder einen Ultimate™ ORF-Klon handelt. In der folgenden Tabelle sind verschiedene verfügbare Zielvektoren aufgeführt.

Zusätzliches Material erforderlich, separat erhältlich: Gateway™-Entry-Klon, geeignete Gateway™ LR Clonase Enzymgemisch und Reaktionspuffer.
Nur für Forschungszwecke. Nicht zur Verwendung bei diagnostischen Verfahren.
Specifications
Konstitutives oder induktives SystemKonstitutiv
LiefertypTransfektion
Zur Verwendung mit (Anwendung)Konstitutive Expression
ProdukttypSäugetier-Expressionsvektor
Menge6μ g
Selektionsmittel (eukaryotisch)Geneticin™ (G-418)
VektorpDEST, pcDNA
KlonierungsmethodeGateway™
ProduktlinieGateway, pcDNA
PromoterCMV
ProteinmarkierungV5-Epitop-Tag
Unit SizeEach
Inhalt und Lagerung
Alle Zielvektoren werden lyophilisiert und superspiralisiert geliefert.

Häufig gestellte Fragen (FAQ)

I performed stable selection but my antibiotic-resistant clones do not express my gene of interest. What could have gone wrong?

Here are possible causes and solutions:

Detection method may not be appropriate or sensitive enough:
- We recommend optimizing the detection protocol or finding more sensitive methods. If the protein is being detected by Coomassie/silver staining, we recommend doing a western blot for increased sensitivity. The presence of endogenous proteins in the lysate may obscure the protein of interest in a Coomassie/silver stain. If available, we recommend using a positive control for the western blot.
- Insufficient number of clones screened: Screen at least 20 clones.
- Inappropriate antibiotic concentration used for stable selection: Make sure the antibiotic kill curve was performed correctly. Since the potency of a given antibiotic depends upon cell type, serum, medium, and culture technique, the dose must be determined each time a stable selection is performed. Even the stable cell lines we offer may be more or less sensitive to the dose we recommend if the medium or serum is significantly different.
- Expression of gene product (even low level) may not be compatible with growth of the cell line: Use an inducible expression system.
- Negative clones may result from preferential linearization at a vector site critical for expression of the gene of interest: Linearize the vector at a site that is not critical for expression, such as within the bacterial resistance marker.

I used a mammalian expression vector but do not get any expression of my protein. Can you help me troubleshoot?

Here are possible causes and solutions:

- Try the control expression that is included in the kit
Possible detection problem:

- Detection of expressed protein may not be possible in a transient transfection, since the transfection efficiency may be too low for detection by methods that assess the entire transfected population. We recommend optimizing the transfection efficiency, doing stable selection, or using methods that permit examination of individual cells. You can also increase the level of expression by changing the promoter or cell type.
- Expression within the cell may be too low for the chosen detection method. We recommend optimizing the detection protocol or finding more sensitive methods. If the protein is being detected by Coomassie/silver staining, we recommend doing a western blot for increased sensitivity. The presence of endogenous proteins in the lysate may obscure the protein of interest in a Coomassie/silver stain. If available, we recommend using a positive control for the western blot. Protein might be degraded or truncated: Check on a Northern. Possible time-course issue: Since the expression of a protein over time will depend upon the nature of the protein, we always recommend doing a time course for expression. A pilot time-course assay will help to determine the optimal window for expression. Possible cloning issues: Verify clones by restriction digestion and/or sequencing.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

I am using a mammalian expression vector that has the neomycin resistance gene. Can I use neomycin for stable selection in mammalian cells?

No; neomycin is toxic to mammalian cells. We recommend using Geneticin (a.k.a. G418 Sulfate), as it is a less toxic and very effective alternative for selection in mammalian cells.

Is it okay if my construct has an ATG that is upstream of the ATG in my gene of interest? Will it interfere with translation of my gene?

Translation initiation will occur at the first ATG encountered by the ribosome, although in the absence of a Kozak sequence, initiation will be relatively weak. Any insert downstream would express a fusion protein if it is in frame with this initial ATG, but levels of expressed protein are predicted to be low if there is a non-Kozak consensus sequence. If the vector contains a non-Kozak consensus ATG, we recommend that you clone your gene upstream of that ATG and include a Kozak sequence for optimal expression.

Do you offer a GFP-expressing mammalian expression vector that I can use as a control to monitor my transfection and expression?

We offer pJTI R4 Exp CMV EmGFP pA Vector, Cat. No. A14146, which you can use to monitor your transfection and expression.

Zitierungen und Referenzen (2)

Zitierungen und Referenzen
Abstract
Endogenous Msx1 antisense transcript: in vivo and in vitro evidences, structure, and potential involvement in skeleton development in mammals.
Authors: Blin-Wakkach C; Lezot F; Ghoul-Mazgar S; Hotton D; Monteiro S; Teillaud C; Pibouin L; Orestes-Cardoso S; Papagerakis P; Macdougall M; Robert B; Berdal A;
Journal:Proc Natl Acad Sci U S A
PubMed ID:11390985
'Msx1 is a key factor for the development of tooth and craniofacial skeleton and has been proposed to play a pivotal role in terminal cell differentiation. In this paper, we demonstrated the presence of an endogenous Msx1 antisense RNA (Msx1-AS RNA) in mice, rats, and humans. In situ analysis revealed ... More
Serinc, an activity-regulated protein family, incorporates serine into membrane lipid synthesis.
Authors:Inuzuka M, Hayakawa M, Ingi T,
Journal:J Biol Chem
PubMed ID:16120614
Cell membranes contain various transporter proteins, some of which are responsible for transferring amino acids across membrane. In this study, we report another class of carrier proteins, termed Serinc1-5, that incorporates a polar amino acid serine into membranes and facilitates the synthesis of two serine-derived lipids, phosphatidylserine and sphingolipids. Serinc ... More